Antibody tests for identification of current and past infection with SARS‐CoV‐2
T Fox, J Geppert, J Dinnes, K Scandrett… - Cochrane database …, 2022 - cochranelibrary.com
Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays
A La Marca, M Capuzzo, T Paglia, L Roli… - Reproductive …, 2020 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated
coronavirus disease 2019 (COVID-19) pandemic has demanded rapid upscaling of in-vitro …
coronavirus disease 2019 (COVID-19) pandemic has demanded rapid upscaling of in-vitro …
COVID-19 antibody tests and their limitations
G Liu, JF Rusling - ACS sensors, 2021 - ACS Publications
COVID-19, caused by the SARS-CoV-2 virus, has developed into a global health crisis,
causing over 2 million deaths and changing people's daily life the world over. Current main …
causing over 2 million deaths and changing people's daily life the world over. Current main …
Interleukin-6 as prognosticator in patients with COVID-19
E Grifoni, A Valoriani, F Cei, R Lamanna… - Journal of …, 2020 - journalofinfection.com
The recurrence of seasonal influenza epidemics is attributed to the continuous evolution of
influenza viruses, which enables them to change pathogenicity and escape from human …
influenza viruses, which enables them to change pathogenicity and escape from human …
Early detection of SARS-CoV-2 seroconversion in humans with aggregation-induced near-infrared emission nanoparticle-labeled lateral flow immunoassay
R Chen, C Ren, M Liu, X Ge, M Qu, X Zhou, M Liang… - ACS …, 2021 - ACS Publications
An outbreak of coronavirus disease (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) poses great threats to human health and the …
syndrome coronavirus 2 (SARS-CoV-2) poses great threats to human health and the …
Microfluidics-based point-of-care testing (POCT) devices in dealing with waves of COVID-19 pandemic: the emerging solution
Recent advances in microfluidics-based point-of-care testing (POCT) technology such as
paper, array, and beads have shown promising results for diagnosing various infectious …
paper, array, and beads have shown promising results for diagnosing various infectious …
Lack of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a large cohort of previously infected persons
LR Petersen, S Sami, N Vuong… - Clinical Infectious …, 2021 - academic.oup.com
Background Reports suggest that some persons previously infected with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) lack detectable immunoglobulin G (IgG) …
respiratory syndrome coronavirus 2 (SARS-CoV-2) lack detectable immunoglobulin G (IgG) …
[HTML][HTML] Anti-spike, anti-nucleocapsid and neutralizing antibodies in SARS-CoV-2 inpatients and asymptomatic individuals
E Brochot, B Demey, A Touzé, S Belouzard… - Frontiers in …, 2020 - frontiersin.org
A better understanding of the anti-SARS-CoV-2 immune response is necessary to finely
evaluate commercial serological assays but also to predict protection against reinfection and …
evaluate commercial serological assays but also to predict protection against reinfection and …
A comparative review of immunoassays for COVID-19 detection
Introduction: The gold standard for diagnosis of coronavirus disease 2019 (COVID-19) is
detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by reverse …
detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by reverse …
Temperature-dependent surface stability of SARS-CoV-2
The recurrence of seasonal influenza epidemics is attributed to the continuous evolution of
influenza viruses, which enables them to change pathogenicity and escape from human …
influenza viruses, which enables them to change pathogenicity and escape from human …